462510 — Lameditech Co Balance Sheet
0.000.00%
- KR₩37bn
- KR₩41bn
- KR₩7bn
Annual balance sheet for Lameditech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | KAS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,931 | 3,729 | 6,049 | 11,159 | 8,554 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 144 | 86.2 | 741 | 942 | 1,173 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,111 | 5,517 | 8,711 | 15,487 | 16,898 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,650 | 2,194 | 2,390 | 6,087 | 7,506 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,861 | 7,856 | 11,278 | 22,346 | 25,200 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 486 | 17,971 | 1,185 | 1,283 | 10,230 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,262 | 19,609 | 2,726 | 3,192 | 16,780 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 6,600 | -11,753 | 8,551 | 19,154 | 8,420 |
| Total Liabilities & Shareholders' Equity | 8,861 | 7,856 | 11,278 | 22,346 | 25,200 |
| Total Common Shares Outstanding |